CONTENTS OF VASCULITIS ENDOTHELIAL GROWTH FACTOR IN SERUM OF PATIENTS WITH TYPE 2 DIABETES WITH DIFFERENT BODY WEIGHT AND IN OBESE

Authors

  • Mogylnytska L. A. Khmelnytsky regional hospital

DOI:

https://doi.org/10.21856/j-PEP.2015.2.09

Keywords:

vasculitis endothelial growth factor, type 2 diabetes, obesity, endothelial dysfunction.

Abstract

In a result of research it was revealed elevated levels of vasculitis endothelial growth factor in the serum of patients with type 2 diabetes and in patients with obesity without diabetes. It was found that elevated levels of vascular endothelial growth factor vasculitis associated with hyperglycemia and dyslipidemia in patients with type 2 diabetes and normal body weight. In patients with type 2 diabetes and obesity and in patients with obesity without diabetes increase of vasculitis endothelial growth factor is associated with body mass index, an indicator of insulin resistance and lipid metabolism. It was identify changes point to the development of endothelial dysfunction in patients with type 2 diabetes with different weight and patients with obesity without diabetes.

References

World Health Organization. Global Status Report on Noncommunicable Diseases 2010-2011.

Olokoba AB, Obateru OA, Olokoba LB. Oman Med J 2012; 27(4): 269-273.

Basha B, Samuel SM, Triggle CR, et al. Exp Diabetes Res 2012; 2012: 481840.

Jansson PA. J Intern Med 2007; 262(2): 173-183.

Ruszkowska-Ciastek B, Sokup A, Socha MW, et al. J Zhejiang Univ Sci B 2014; 15(6): 575-581.

Rask-Madsen C, King GL. Cell Metab 2013; 17(1): 20-33.

Zakareia FA. Biomarkers Med 2012; 6: 81-87.

Nakagawa T, Sato W, Kosugi T, Johnson RJ. J Diabetes Res 2013; 2013: 184539.

Lim HS, Lip GY, Blann AD. Atherosclerosis 2005; 180(1): 113-118.

Lim HS, Chong AY, Freestone B, et al. Diabet Med 2005; 22(3): 249-255.

ErŽen B, Šilar M, Šabovič M. BMC Cardiovasc Dis 2014; 22: 164-166.

Kohner EM, Porta M. Eur J Ophthalmol 1991; 1(1): 45-54.

Mogensen CE, Christensen CK, Vittinghus E. Diabetes 1983; 32(2): 64-78.

Kubisz P, Chudy P, Staśko J, et al. Acta Diabetol 2010; 47(2): 119-124.

Mahdy RA, Nada WM, Hadhoud KM, El-Tarhony SA. Eye (Lond) 2010; 24(10): 1576-1584.

Wada H, Ura S, Kitajka S, et al. PLoS ONE 2011; 6(12): 29351.

Bornfeldt KE, Tabas I. Cell Metab 2011; 14(5):575-585.

Pansuria M, Xi H, Li L, et al. Front Biosci (ScholEd) 2012; 4: 916-931.

Downloads

Published

2021-08-18

How to Cite

Могильницька, . Л. А. (2021). CONTENTS OF VASCULITIS ENDOTHELIAL GROWTH FACTOR IN SERUM OF PATIENTS WITH TYPE 2 DIABETES WITH DIFFERENT BODY WEIGHT AND IN OBESE. Problems of Endocrine Pathology, 52(2), 62-69. https://doi.org/10.21856/j-PEP.2015.2.09

Issue

Section

CLINICAL ENDOCRINOLOGY